MANILA, March 2 (Reuters) - China's Sinopharm has applied
for emergency use of its COVID-19 vaccine in the Philippines,
the chief of Manila's Food and Drug Administration (FDA) said on
Tuesday.
Sinopharm is the sixth vaccine maker to apply for emergency
use authorisation in the Southeast Asian country. The
Philippines, which has the second-highest number of COVID-19
cases and deaths in Southeast Asia, has approved the vaccines of
Pfizer, AstraZeneca (NASDAQ:AZN) and Sinovac for emergency use.